VIKTORIYA BUSKO: Open Payments
NPI 1851003586 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 61 payments from 18 companies in 2025. Trend: 2023 $1,672 · 2024 $1,377 · 2025 $1,490
Food & beverage: $1,455Speaker / faculty: $35
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $216 |
| MDD US Operations, LLC | 15 | $190 |
| Medtronic, Inc. | 3 | $186 |
| Biogen, Inc. | 3 | $170 |
| MicroTransponder, Inc. | 1 | $139 |
| TG Therapeutics, Inc. | 1 | $105 |
| ABBVIE INC. | 6 | $95 |
| Genentech USA, Inc. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $71 |
| Merz Pharmaceuticals, LLC | 2 | $54 |
Products named: AUSTEDO XR, PERCEPT PC BRAINSENSE, VUMERITY, Apokyn, BRIUMVI, Ocrevus Zunovo, UBRELVY, Xeomin.
Industry payments across NJ — which companies pay providers there.
